International News: European Union health regulator warns of decreasing effectiveness of COVID-19 antibody therapies

Published by BBNTEAM at December 9, 2022

Tags

Posted: Friday, December 9, 2022. 1:30 pm CST.

By Zoila Palma Gonzalez: Today, the European Union’s health regulator warned of the decreasing effectiveness of COVID-19 antibody therapies to treat patients since there are new emerging virus variants, Reuters report.

The World Health Organization (WHO) has pulled recommendations for some monoclonal antibodies on the basis that Omicron and the variant’s latest offshoots have likely rendered these options obsolete.

Since the virus continues to evolve, it has posed challenges to health experts.

The European Medicines Agency is advising health professionals to consider alternative treatments especially if subvariants such as BQ.1 and BQ.1.1 become prevalent.

The new variants of the dominant BA.5 subvariant of Omicron are known as BQ.1 and BQ.1.1.

At this time, health experts believe that Pfizer’s Paxlovid and Gilead’s remdesivir can be considered to treat patients.

Advertise with the mоѕt vіѕіtеd nеwѕ ѕіtе іn Belize ~ We offer fully customizable and flexible digital marketing packages. Your content is delivered instantly to thousands of users in Belize and abroad! Contact us at mаrkеtіng@brеаkіngbеlіzеnеwѕ.соm or call us at 501-612-0315.